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Abstract
We evaluated the effects of chronic oral supplementation with L-glutamine and L-alanine in their free form or as the dipeptide L-alanyl-
L-glutamine (DIP) on muscle damage, inflammation and cytoprotection, in rats submitted to progressive resistance exercise (RE). Wistar rats
(n 8/group) were submitted to 8-week RE, which consisted of climbing a ladder with progressive loads. In the final 21 d before euthanasia,
supplements were delivered in a 4% solution in drinking water. Glutamine, creatine kinase (CK), lactate dehydrogenase (LDH), TNF-α,
specific IL (IL-1β, IL-6 and IL-10) and monocyte chemoattractant protein-1 (MCP-1) levels were evaluated in plasma. The concentrations of
glutamine, TNF-α, IL-6 and IL-10, as well as NF-κB activation, were determined in extensor digitorum longus (EDL) skeletal muscle. HSP70
level was assayed in EDL and peripheral blood mononuclear cells (PBMC). RE reduced glutamine concentration in plasma and EDL (P< 0·05
v. sedentary group). However, L-glutamine supplements (L-alanine plus L-glutamine (GLN+ALA) and DIP groups) restored glutamine levels in
plasma (by 40 and 58%, respectively) and muscle (by 93 and 105%, respectively). GLN+ALA and DIP groups also exhibited increased level of
HSP70 in EDL and PBMC, consistent with the reduction of NF-κB p65 activation and cytokines in EDL. Muscle protection was also indicated by
attenuation in plasma levels of CK, LDH, TNF-α and IL-1β, as well as an increase in IL-6, IL-10 and MCP-1. Our study demonstrates that chronic
oral L-glutamine treatment (given with L-alanine or as dipeptide) following progressive RE induces cyprotective effects mediated by HSP70-
associated responses to muscle damage and inflammation.
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The most abundant amino acid in the body, glutamine, is
considered conditionally essential during stress and plays a key
role in the inter-organ N transport(1), intermediary meta-
bolism(2), cellular redox pathways(1), glucose(3) and glutathione
synthesis(4), as well as in several other essential metabolic
processes(5,6). Glutamine is also an important modulator of the
heat-shock protein (HSP) response, via O-glycosylation and
phosphorylation of heat-shock factor 1 (HSF-1)(7,8). HSP,
especially the 70-kDa family (HSP72 +HSP73), are proteins
known as ‘stress response proteins’, as their expression is highly
induced by different types of agents and catabolic stimuli, such
as oxidative, thermal and metabolic stresses, infection and
intense exercise(9). Within the cell, HSP act as molecular
chaperones maintaining cellular homoeostasis, protecting
against injury and death(9) and modulating inflammatory
responses through the NF-κB signalling pathway(10). Recently,
HSP70 was shown to act as a regulator of the early inflamma-
tory response to muscle injury, because of its role in myofibre
regeneration and recovery(11).
In sport and exercise, glutamine supplementation is popular
among athletes, as it is considered an important nutrient for
immune function and muscle recovery from injury and
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catabolism(12). In fact, glutamine is a critical fuel for immune cell
function and proliferation(5,13), and its major supply is from the
skeletal muscle, which indicates a tight relationship between
muscle and immune function. However, the efficacy of oral
L-glutamine supplementation has raised many questions(4,13–17).
As studies in humans and animals have described the extensive
intestinal metabolism of dietary glutamine(18,19), the dipeptide
L-alanyl-L-glutamine (DIP) has been utilised for several
clinical(20–22) and sports nutrition studies(16,23–25) as an alter-
native delivery form via oral administration. The effectiveness of
DIP has been related to the intestinal peptide transporter 1,
which facilitates a wide broad of dipeptide and tripeptide
absorption(26,27). The dipeptide also allows for a supply of more
glutamine molecules at the physiological osmolality required
for oral solutions(22).
Studies in animal models subjected to intense and exhaustive
aerobic exercise(4,28), or subjected to infection(29,30), have
provided evidence that both DIP and free forms of L-glutamine,
along with L-alanine supplementation, improve glutamine
availability and mitigate muscle damage and related inflam-
mation. Thus, L-alanine supplementation may be important for
glutamine metabolism(24,31). Considering that progressive
resistance exercise (RE) is a commonly used form of exercise
and the rat model can mimic human responses to exercise(32),
the purpose of the present study was to investigate the effects of
chronic oral supplementation with L-glutamine and L-alanine, in
their free or DIP forms, on muscle damage and inflammation in
rats submitted to RE. We hypothesised that supplements
containing L-alanine and L-glutamine could favour glutamine
metabolism in skeletal muscle composed of fast-twitch fibres,
such as the extensor digitorum longus (EDL), and increase the
levels of HSP70 in both active muscle and circulating peripheral
blood mononuclear cells (PBMC), attenuating the harmful
inflammatory effects of heavy RE.
Methods
Animals
Male Wistar rats (n 40), aged 2 months and weighing 228·78
(SD 2·03) g, were obtained from the animal facility of the Faculty
of Pharmaceutical Sciences at University of São Paulo and
housed one per cage with free access to water and standard
chow (NUVILAB CR1; Nuvital Nutrients), composed of 22%
protein. The animals were kept under a 12 h light–12 h dark
cycle (lights on 16.00 hours, lights off 04.00 hours), at a room
temperature of 22± 2°C and relative humidity of 55± 10%, for
8 weeks. Food intake and body weight were registered three
times per week, fluid intake was assessed daily and the final
weight was determined before euthanasia.
All animals were allowed to adapt to the laboratory
environment for 1 week before the beginning of the experi-
mental protocol. After the adaptation period, the animals were
weighed and randomly distributed into five groups (n 8/group):
sedentary (SED), trained control (CTRL) and trained supple-
mented with L-alanine (ALA), L-alanine plus L-glutamine
(GLN+ALA) or L-alanyl-L-glutamine (DIP). All procedures were
approved by the Ethics Committee for Animal Experimentation
of the Faculty of Pharmaceutical Sciences, University of São
Paulo, according to the guidelines of the Brazilian College of
Animal Experimentation (protocol number: CEUA/FCF/428).
Resistance exercise protocol
The 8-week exercise protocol was adapted from Scheffer
et al.(33), originally published by Hornberger & Farrar(34), which
consisted of climbing a vertical ladder (1·1× 0·18m, 2 cm grid,
80° inclined) with progressive loads secured to the base of the
rats tail. During the adaptation period (2 weeks), all animals
were familiarised to the apparatus carrying a load equal to 5%
of the body weight. Then, the load training was progressively
increased to 25, 50, 75 and 100% of the body weight, involving
three to six sets of eight repetitions, with 2-min break between
sets. Each day of exercise was considered one session, and it
was repeated every 48 h.
Three tests of maximum carrying capacity (MCC) were
performed to determine exercise performance as follows:
after adaptation period (test 1), before supplementation (test 2)
and after supplementation (test 3). Briefly, the test protocol
consisted of a ladder climb with an initial load of 75% of
body weight, plus an additional 30 g load on each climb
until exhaustion, with 2min of rest period. This procedure
was successively repeated and the highest load carried was
considered the MCC final result.
Supplementation
Supplements were diluted in the drinking water at a concentra-
tion of 4% (4 g dissolved in a final volume of 100ml) and offered
ad libitum in the last 21d of the experiment. Administration in
the drinking water was selected after technical difficulties in
administering daily oral gavages and in an attempt to reduce the
stress of manipulation, as well as to increase the frequency of
amino acid intake throughout the day(35). The total amount of
amino acids in each administered supplement was calculated
based on the commercial DIP concentration (Dipeptiven®; 20 g
of L-alanyl-L-glutamine dissolved in 100ml of water). Free
L-glutamine and free L-alanine were manufactured by Labsynth
(Synth), whereas Dipeptiven® was manufactured by Fresenius
Kabi S.A. Supplement intake was measured daily.
Plasma parameters and peripheral blood mononuclear
cell isolation
Blood lactate was determined during RE training every third
session of each training load (25, 50, 75 and 100% of body
weight). Samples were collected from the tail vein into hepar-
inised tubes and assayed in a lactometer, Yellow Spring Instru-
ments (YSI Life Science). A duration of 1 h after the last session of
RE, animals were killed by decapitation and blood was imme-
diately collected into heparinized tubes and stored at −80°C.
In this study, we analysed the blood buffy coat composed of
PBMC (lymphocytes, monocytes and dendritic cells). For PBMC
isolation, fresh blood samples were diluted 1:1 in PBS/EDTA
(2mM) and combined with an equal volume of Ficoll–Hypaque
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solution (Ficoll 400: F4375 and Hypaque: S4506; Sigma-Aldrich)
according to the gradient separation method described in the
study by Bøyum et al.(36). Then, PBMC were aspirated and
suspended on ice-cold radioimmunoprecipitation assay (RIPA)
buffer containing protease and phosphatase inhibitors (Cell
Signaling Technology).
Plasma activity of creatine kinase (CK) and lactate dehy-
drogenase (LDH) was determined with a commercial kit
(Labtest). IL-1β, IL-6, IL-10, TNF-α and monocyte chemoat-
tractant protein-1 (MCP-1) levels were measured by the
Luminex beads assay, using the Milliplex MAP Kit for Luminex
200 reader, according to the manufacturer’s instructions
(Millipore Corp.). Glutamine and glutamate concentrations
were determined spectrophotometrically using a commercial kit
(Sigma-Aldrich) adapted for microplate reader (Synergy H1
Hybrid wavelength; BioTek).
Tissue measurements
EDL skeletal muscle was surgically excised after euthanasia and
immediately frozen in liquid N2 for subsequent analysis. Muscle
glutamine and glutamate concentrations were determined as
described by Lund(37). Mean values were reported as micro-
moles of glutamine per gram of fresh tissue and as nmol of
glutamine/mg of protein. Muscle protein content was quantified
using the BCA Protein Assay kit (Pierce; Thermo Scientific). For
IL-6, IL-10 and TNF-α analysis, muscle samples (250mg) were
homogenised in 1ml of PBS buffer containing protease and
phosphatase inhibitors, and performed according to the
immunoassay kit (Millipore).
Total DNA-binding activity of NF-κB p65 was determined in
the nuclear extract of EDL muscle by electrophoretic mobility
shift assay. Nuclear fractions were isolated and analysed as per
the manufacturer’s instructions using the NF-κB p50/p65 trans-
cription factor assay kit (Abcam). NF-κB p65 was detected at
450 nm. Data were shown as optical density normalised by
corresponding nuclear protein concentration, which allows
semi-quantitative comparisons of the relative amounts of
nuclear NF-κB p65 among groups.
Western blot analysis
After homogenisation with RIPA buffer containing protease and
phosphatase inhibitors, EDL skeletal muscle and PBMC lysates
were combined with sample buffer containing 240mM-Tris
(pH 6·8), 40% Glycerol, 0·8% SDS, 200mM-β-mercaptoethanol
and 0·02% bromophenol blue. Amounts of protein (40 µg) were
subjected to SDS-PAGE and transferred onto nitrocellulose
membranes (GE Healthcare).
Membranes were blocked with 0·5% bovine serum albumin
(BSA; Sigma-Aldrich) diluted in PBS with Tween (PBST),
washed and incubated at 4°C with gentle shaking overnight,
with primary antibody HSP70 1:1000 (Cell Signaling Technol-
ogy). After three washes, membranes were incubated for 1 h
with peroxidase-labelled anti-rabbit IgG antibodies (Cell
Signaling Technology) diluted 1:5000 in PBST and 2% BSA.
Blots were visualised on ImageQuant 400 (GE Healthcare) with
a 1:1 solution of ECL-Advance Western blotting Reagent (GE
Healthcare). Monoclonal anti-β-actin-peroxidase antibody
(Sigma-Aldrich) at a ratio of 1:25 000 was used for gel loading
control and protein normalisation. The densitometric analysis of
the Western blot was performed by the protein level average,
normalised to β-actin.
Statistical analysis
Comparisons among groups were carried out by one-way
ANOVA with Tukey’s honestly significant differences as a post
hoc test. Analyses over multiple time points were performed with
repeated measures. Pearson’s correlation coefficient (r) was used
as a measure of association. The level of statistical significance
was set at P< 0·05. Data were analysed using Prism 5.0 for
windows and expressed as mean values and standard deviations.
Results
Body weight, food and fluid intake
Body weight gain and food intake were reduced (by 30 and
11%, respectively) in trained CTRL compared with the SED
group (P< 0·05). However, no differences were observed
among trained groups before the supplementation period (data
not shown). As depicted in Table 1, RE training attenuated body
weight gain and food intake in CTRL group (P< 0·05 v. SED)
throughout the supplementation period, and no difference was
found in water intake between SED and CTRL groups. Although
supplement intake was higher in ALA (65·14 (SD 2·92)ml/d)
than in GLN+ALA and DIP groups (60·15 (SD 1·90) and 52·75
Table 1. Body weight gain, food and fluid intake of rats submitted to resistance exercise and evaluated during 3-week supplementation period§
(Mean values and standard deviations; n 8)
SED CTRL ALA GLN+ALA DIP
Mean SD Mean SD Mean SD Mean SD Mean SD
Body weight gain (%) 13·11 1·77 7·17* 2·17 6·28* 3·22 7·35* 2·80 8·11* 1·72
Food intake (g/d) 27·08 0·65 23·00* 1·92 22·15* 2·04 21·69* 0·53 21·66* 0·32
Fluid intake (ml/d) 39·06 2·12 37·88 2·16 65·14*†‡ 7·16 60·15*† 4·64 52·75*† 4·66
SED, sedentary group; CTRL, trained control; ALA, trained supplemented with L-alanine; GLN+ALA, trained supplemented with L-glutamine plus L-alanine in free form; DIP, trained
supplemented with L-alanyl-L-glutamine.
* P<0·05 v. SED.
† P<0·05 v. CTRL.
‡ P<0·05 v. DIP.
§ SED and CTRL received water and supplements given in a 4% solution.
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(SD 1·90)ml/d, respectively), as well as in all supplemented
groups compared with CTRL (P< 0·05), L-glutamine or L-alanine
administrations did not affect weight gain and food intake.
Maximum carrying capacity performance test and the
lactate response
The MCC test represents a method to determine exercise
performance(34). As depicted in Fig. 1, all trained animals
demonstrated increased performance (P< 0·05) in tests 2 and 3
(approximately 32 and 50%, respectively) when compared with
the first test. However, it is noteworthy that no difference was
observed between test 2 and test 3, which suggests a lower
carrying capacity induced by high-intensity RE. Although
L-glutamine is expected to be useful to replenish amino acid
body stores, it is unlikely that this nutritional supplementation
can enhance performance, as previously reported(15,38,39). In
fact, the MCC test results demonstrated no significant difference
between controls and supplemented animals (Fig. 1).
Lactate concentration was determined in four different time
points to evaluate exercise intensity and metabolic demand.
As illustrated in Fig. 2, controls exhibited blood lactate 2-fold
higher at a load of 100% compared with all previous loads
(P< 0·05), suggesting increased energy demand promoted by
RE. In the supplemented groups, lactate at 100% of BW
increased approximately 80%, which was statistically significant
when compared with the 25% load (P< 0·05). Moreover,
both L-glutamine-supplemented groups were associated with
lower lactate concentration at 100%, when compared with the
controls (P< 0·05).
Glutamine metabolism in plasma and skeletal muscle
Because of the increased requirements triggered by heavy exer-
cise training, the concentration of glutamine in plasma and tissues
falls sharply, especially in major stores of the amino acid for the
whole body, such as the skeletal muscle. The results presented
herein demonstrated that RE training compromised both plasma
(Table 2) and muscle (Table 3) glutamine levels, and the muscle
glutamine:glutamate ratio (Table 3) in the controls, when com-
pared with SED animals (P< 0·05). In contrast, the nutritional
interventions with ALA, GLN+ALA and DIP reduced the severity
of RE effects, increasing plasma glutamine concentration (by 45,
40 and 57%, respectively), when compared with the CTRL group
(P< 0·05). Moreover, muscle glutamine concentrations were
significantly restored (both μmol/g fresh tissue and nmol/mg
protein) in GLN+ALA and DIP groups (Table 3).
Although the amino acid intake was increased in supple-
mented groups (by 33%) compared with CTRL, no significant
correlation was observed between amino acid intake and the
concentrations of glutamine in plasma of ALA (r −0·28,
P= 0·59), GLN+ALA (r −0·42, P= 0·40) and DIP (r −0·40,
P= 0·42) groups, as well as in muscle (r 0·04, P= 0·93;
r 0·33, P= 0·52; r 0·10, P= 0·85, respectively).
Muscle damage and inflammation in plasma
and skeletal muscle
Assessing plasma markers of muscle damage involved deter-
mination of the activity of CK and LDH. This was high in the
controls (56 and 39%, respectively) as compared with the SED
group (Table 2, P< 0·05). However, this effect was attenuated
by GLN+ALA and DIP supplementation, when compared with
the CTRL group (P< 0·05).
Besides elevations in CK and LDH, RE increased plasma IL-1β
by 75%, TNF-α by 14%, IL-6 by 45%, IL-10 by 46% and MCP-1
by 33% in the CTRL group as compared with SED (P< 0·05).
Nevertheless, nutritional interventions with ALA, GLN+ALA
and DIP reduced plasma concentrations of IL-1β and TNF-α
(by 57 and 21%, respectively), when compared with controls
(P< 0·05). Interestingly, animals supplemented with GLN+ALA
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Fig. 1. Maximum carrying capacity (MCC) test was performed before
supplementation (test 1 and test 2) and after supplementation period (test 3)
over the course of resistance exercise protocol. Values are means (n 8), and
standard deviations. * P< 0·05 test 1 v. test 2; ** P< 0·01 test 1 v. test 3.
, Trained control group; , trained supplemented with L-alanine;
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Fig. 2. Levels of blood lactate in rats submitted to progressive resistance
training. Lactate was assessed in four time points, every third session of each
training load (25, 50, 75 and 100% of body weight). Trained control group
(CTRL, ) received water; ALA ( ), GLN+ALA ( ) and DIP
( ) were supplemented with L-alanine, L-alanine plus L-glutamine and
L-alanyl-L-glutamine, respectively, in a 4% solution. Values are means (n 8),
and standard deviations. * P< 0·05 v. 25, 50 and 75% of BW load; † P< 0·05 v.
25% of BW load; ‡ P< 0·05 GLN+ALA and DIP v. CTRL. ALA, Trained
supplemented with L-alanine; GLN+ALA, L-glutamine plus L-alanine; DIP,
dipeptide L-alanyl-L-glutamine.
Glutamine effects on resistance exercise 473
http://dx.doi.org/10.1017/S0007114516001999
Downloaded from http:/www.cambridge.org/core. Curtin University Library, on 27 Sep 2016 at 04:28:14, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms.
(38%), IL-10 (91%) and MCP-1 (28%), as compared with the
CTRL group (Table 2, P< 0·05).
As depicted in Table 3, both RE training and nutritional
supplementation had an impact on muscle inflammation. In the
CTRL group, inflammatory mediators such as TNF-α, IL-6 and
IL-10 increased because of the RE training protocol, when
compared with SED animals (P< 0·05). However, ALA, GLN+
ALA and DIP supplements attenuated this finding (P< 0·05 v.
CTRL group), maintaining the concentration of muscle TNF-α,
IL-6 and IL-10 close to basal levels observed in the SED group.
Glutamine effects on HSP70 response and muscle
NF-κB activation
HSP, especially the HSP70 family (the major HSP), provide
critical protection against several forms of injury. Although
exercise is a potent stimulus for the HSP response, local and
systemic inflammatory injury leads to a deficit in HSP70 protein
levels, which may impair recovery. Herein, muscle HSP70 level
was markedly reduced (by 51%) by RE training in the controls,
as compared with SED animals (Fig. 3, P< 0·05). Moreover, RE
produced a severe decrease (by 88%) in HSP70 levels in cir-
culating PBMC (Fig. 4, P< 0·05) possibly because these cells are
unable to synthesise glutamine and are largely dependent on
plasma and muscle glutamine availability, which is compro-
mised by RE. In fact, glutamine availability is critical for the
optimal regulation of HSP response. Indeed, GLN+ALA and
DIP supplements were able to restore HSP70 concentration in
both EDL skeletal muscle (Fig. 3) and PBMC (Fig. 4), when
compared with CTRL animals (P< 0·05).
Intracellular HSP70 have important anti-inflammatory properties,
providing stress tolerance by blocking the activation of the NF-κB
pathway(30,40). Our results with RE training are in agreement with
in vitro and aerobic exercise studies, since decreased HSP70 levels
promoted inflammatory effects by enhancing the activation of
NF-κB p65 in the skeletal muscle of controls by 34%, as compared
with the SED group (Fig. 5, P<0·05). Moreover, glutamine is a key
substrate that has an impact on HSP70 expression. Consequently,
the increased HSP70 levels found in EDL reduced (by 30%) NF-κB
p65 activation, when compared with controls (P<0·05).
Table 2. Glutamine, glutamate and markers of muscle damage and inflammation in plasma of rats submitted to 8-week resistance exercise§
(Mean values and standard deviations; n 8)
SED CTRL ALA GLN+ALA DIP
Mean SD Mean SD Mean SD Mean SD Mean SD
Gln (µmol/l) 1·15 0·03 0·99* 0·10 1·44† 0·11 1·39† 0·20 1·56*† 0·37
Glu (µmol/l) 0·83 0·25 0·79 0·31 0·76 0·27 0·79 0·30 0·73 0·36
CK (U/ml) 12·10 2·23 18·83* 2·62 16·32‡ 5·20 10·27† 4·60 9·82† 3·03
LDH (U/ml) 5·13 0·77 7·12* 1·33 5·30 1·65 4·55† 1·35 4·77† 1·08
IL-1β (pg/ml) 0·08 0·03 0·14* 0·03 0·07† 0·04 0·06† 0·04 0·05† 0·03
TNF-α (pg/ml) 1·77 0·02 2·05* 0·07 1·68† 0·09 1·69† 0·08 1·52† 0·08
IL-6 (pg/ml) 7·38 2·10 10·72* 2·30 11·18*‡ 1·51 14·92*† 2·65 14·70*† 2·08
IL-10 (pg/ml) 0·95 0·23 1·39* 0·14 1·53*‡ 0·52 2·67*† 0·48 2·64*† 0·35
MCP-1 (pg/ml) 309·72 85·86 412·9* 64·87 432·80* 37·52 518·10*† 69·95 533·90*† 88·81
SED, sedentary group; CTRL, trained control; ALA, trained supplemented with L-alanine; GLN+ALA, trained supplemented with L-glutamine plus L-alanine in free form; DIP, trained
supplemented with L-alanyl-L-glutamine; CK, creatine kinase; LDH, lactate dehydrogenase; MCP-1, monocyte chemoattractant protein-1.
* P<0·05 v. SED.
† P<0·05 v. CTRL.
‡ P<0·05 v. GLN+ALA and DIP.
§ SED and CTRL received water and supplements given in a 4% solution.
Table 3. Skeletal muscle contents of glutamine and glutamate and inflammation markers of rats submitted to 8-week resistance exercise‡
(Mean values and standard deviations; n 8)
SED CTRL ALA GLN+ALA DIP
Mean SD Mean SD Mean SD Mean SD Mean SD
Gln (μmol/g fresh tissue) 8·59 0·21 6·73* 0·75 8·00 1·43 8·77† 0·52 9·05† 1·05
Glu (μmol/g fresh tissue) 6·18 0·45 6·26 0·10 6·28 0·10 6·44 0·25 6·32 0·08
Gln/Glu 1·40 0·06 0·99* 0·21 1·27 0·26 1·31† 0·15 1·37† 0·24
Gln (nmol/mg protein) 20·46 3·27 11·94* 4·23 22·44 11·12 23·06† 2·55 24·51† 10·63
Glu (nmol/mg protein) 13·98 4·92 18·23 8·08 18·80 7·41 17·94 2·48 14·45 3·66
Gln/Glu 1·41 0·04 0·99* 0·05 1·27 0·34 1·31† 0·17 1·33† 0·23
TNF-α (pg/mg protein) 0·12 0·01 0·14* 0·01 0·10† 0·02 0·09† 0·02 0·09† 0·02
IL-6 (pg/mg protein) 6·61 0·75 8·35* 0·98 6·11† 1·17 6·11† 1·07 5·93† 1·10
IL-10 (pg/mg protein) 0·60 0·18 1·13* 0·20 0·62† 0·24 0·61† 0·19 0·58† 0·07
SED, sedentary group; CTRL, trained control; ALA, trained supplemented with L-alanine; GLN+ALA, trained supplemented with L-glutamine plus L-alanine in free form; DIP, trained
supplemented with L-alanyl-L-glutamine.
* P<0·05 v. SED.
† P<0·05 v. CTRL.
‡ SED and CTRL received water and supplements given in a 4% solution.
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Discussion
Our study demonstrated that chronic oral L-glutamine treatment
(in free form along with L-alanine or as dipeptide) following
progressive RE promotes cyprotective effects involving HSP70
responses, thus reducing muscle damage and inflammation.
Glutamine is widely accepted as an important amino acid for
cell metabolism and function, serving as a key metabolic
substrate to provide a fuel source and aid N balance(18,19).
Glutamine metabolism and blood concentration is dramatically
compromised under catabolic situations, which include high
intensity and long periods of exercise. Surprisingly, little data
exist on glutamine metabolism following exogenous supply in
predominantly anaerobic activities, such as RE training.
As described herein, RE resulted in lower glutamine con-
centrations in plasma and EDL muscle. Muscle tissue is quantita-
tively the largest biosynthetic source and is essential for glutamine
production and release, influencing plasma glutamine con-
centration, as well as its utilisation by other tissues and cells such
as PBMC(5,13,24,41). Although glutamine accounts for at least 50%
of the free pool of amino acids in skeletal muscle, under catabolic
situations the release of glutamine from muscle exceeds synthesis,
and it may impair recovery from muscle damage because of the
enhanced rate of protein breakdown induced by N imbalance
following exercise(1,5,24). In the current study, chronic oral
administration with L-glutamine and L-alanine, in their free form or
as the dipeptide, did not influence food intake and body weight
gain, which allowed us to evaluate the exclusive effect of
supplements in trained rats. The beneficial effects described here
are supportive of results published in other studies(4,12,16,23,29).
Interestingly, L-alanine co-supplementation significantly
increased glutamine concentration and effects. Exercise is
characterised by a shift in blood flow from the gastrointestinal
tract to the active muscle, which may lead to changes in intestinal
absorption of glutamine, as demonstrated in catabolic condi-
tions(19). The presence of alanine in supplements containing
glutamine has been shown to alter glutamine metabolism, as it is
metabolised via alanine aminotransferase to pyruvate, and
rapidly consumed in the Krebs Cycle to generate ATP and

































Fig. 4. HSP70 protein levels in peripheral blood mononuclear cells (PBMC) of
rats submitted to resistance exercise. Sedentary (SED) and trained control
(CTRL) groups received water; ALA, GLN+ALA and DIP groups were
submitted to 8-week resistance exercise and supplemented with L-alanine,
L-alanine plus L-glutamine and L-alanyl-L-glutamine, respectively, in a 4%
solution. Supplements were given ad libitum in the last 21 d of the experiment.
Fresh blood samples were collected and peripheral blood mononuclear cells
(PBMC) were separated by Ficoll density gradient centrifugation.
Homogenates were immunoblotted for HSP70 and bands normalised with
β-actin controls. Values are means (n 8), and standard deviations represented
by vertical bars. * P< 0·05 v. SED; † P< 0·05 v. CTRL. ALA, Trained







































SED CTRL GLN + ALA DIPALA
Fig. 5. NF-κB p65 DNA-binding activity in the nuclear extract of extensor
digitorum longus muscle of rats submitted to resistance exercise. Sedentary
(SED) and trained control (CTRL) groups received water; ALA, GLN+ALA and
DIP groups were submitted to 8-week resistance exercise and supplemented
with L-alanine, L-alanine plus L-glutamine and L-alanyl-L-glutamine, respectively,
in a 4% solution. Supplements were given ad libitum in the last 21 d of the
experiment. EDL muscle was excised and frozen in liquid N2 for further
preparation of nuclear extract. Values are means (n 8), and standard deviations
represented by vertical bars. *P< 0·05 v. SED; † P< 0·05 v. CTRL. ALA,


































Fig. 3. HSP70 protein levels in extensor digitorum longus (EDL) muscle of rats
submitted to resistance exercise. Sedentary (SED) and trained control (CTRL)
groups received water; ALA, GLN+ALA and DIP groups were submitted to
8-week resistance exercise and supplemented with L-alanine, L-alanine plus
L-glutamine and L-alanyl-L-glutamine, respectively, in a 4% solution. Supplements
were given ad libitum in the last 21d of the experiment. EDL muscle was excised
and immediately frozen in liquid N2 for further analysis. Homogenates were
immunoblotted for HSP70 and bands were normalised with β-actin controls.
Values are means (n 8), and standard deviations represented by vertical bars.
* P<0·05 v. SED; † P<0·05 v. CTRL. ALA, Trained supplemented with L-alanine;
GLN+ALA, L-glutamine plus L-alanine; DIP, dipeptide L-alanyl-L-glutamine.
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glutamine, alanine has a central role for maintenance of inter-
mediary metabolism(24). Elevated alanine release from muscle
observed during exercise and following training has been con-
sidered necessary to provide a non-toxic form of N transport
from muscle and a substrate for gluconeogenesis in the liver, as
glycolytic flux is increased proportionally to the work intensity
during muscle contractions(44). Thus, despite the fact that high
energy demand evidenced by blood lactate increases in this
study, the high glutamine concentration in plasma of rats treated
with L-alanine supports the concept that alanine supplementa-
tion may supply extra substrate for liver and kidney gluconeo-
genesis sparing glutamine. Oral supplementation with glutamine
given in combination with other amino acids has beneficial
effects on reducing inflammatory cytokine levels(19). Herein, we
have described the beneficial effects of L-alanine supplementa-
tion by reducing pro-inflammatory cytokines; however, admin-
istration of L-alanine alone did not enhance the glutamine
content of skeletal muscle of trained rats.
Glutamine has also been used as an enhancer of HSP 70 kDa
(HSP70) levels(23,45) via O-glycosylation and phosphorylation of
HSF-1(7,8) in both stressed and unstressed animals(45). HSP of
70 kDa (HSP70) is one of the most inducible HSP isoforms and
interacts with other proteins in an ATP-dependent manner,
induced by various stimuli such as exercise, muscle injury and
regeneration(9,46). HSP70 has been considered to play an
important role in regulating skeletal muscle plasticity(23,46,47),
apoptosis and cell death by affecting protein folding, ubiquitin
degradation pathways and protein translocation(48). Recently, a
chaperone balance hypothesis has been proposed. The activa-
tion of NF-κB can result in lower levels of intracellular HSP70,
releasing pro-inflammatory extracellular HSP70, which may act
to reduce oxidative stress in target cells. However, when
chronically elevated, extracellular HSP70 stimulates inflamma-
tion, oxidative stress, reduction of HSF-1 expression and even-
tually reduced intracellular HSP70(49).
In order to investigate the heat-shock response following
progressive RE training, a common form of exercise, we eval-
uated HSP70 protein levels in fast-twitch EDL muscle, a type of
muscle that can generate high-power outputs during exercise(50).
Although exercise is known to stimulate the HSP response, we
report herein that total HSP70 content in EDL muscle markedly
decreased in the CTRL group, which may have been a con-
sequence of impairment of glutamine availability and activation
of NF-κB. The suppression of HSP response was also found in
PBMC, a critical component of the immune system involved in
the muscle repair process after exercise, as these cells are a pri-
mary source of pro-inflammatory cytokine release(51–53). PBMC
are largely dependent on skeletal muscle glutamine synthesis and
release into blood, as these cells do not possess glutamine syn-
thetase to catalyse glutamine synthesis from ammonia and glu-
tamate(15). Glutamine may directly modulate pro-inflammatory
cytokine release in PBMC, which may be related to the heat-
shock response(53). Herein, treatments with DIP and GLN+ALA
evoked a cytoprotective response to damaged tissue mediated by
replenishment of glutamine concentrations, besides increased
HSP70 levels in skeletal muscle and PBMC.
HSP70 has been considered a regulator of the early inflam-
matory response to muscle injury because of its beneficial role in
myofibre regeneration and recovery(11). The increase of HSP70
results in the inhibition of inflammatory cytokine production in
human PBMC(53), as well as by inactivation of the NF-κB
signalling pathway(10,46,54). Our results suggest that HSP70 high
levels attenuated the production of inflammatory cytokines by
inactivation of NF-κB. Inflammatory responses are mediated by
activation of critical signalling pathways, such as
NF-κB(10,55–57). In a single acute exercise bout, the NF-κB activity
in skeletal muscle of rats is increased(58,59). The NF-κB pathway
acts as a central integrator of responses to mechanical, oxidative
and inflammatory stress(54). However, continuous activation and
production of inflammatory components can stimulate excessive
recruitment of immune cells, promoting further tissue injury(60).
Our study demonstrated an increase in NF-κB p65 nuclear activity
in EDL muscle of CTRL animals. Conversely, all nutritional
treatments attenuated the effect of RE. Glutamine can attenuate
the activation of multiple pathways of inflammation such as
NF-κB through the ubiquitin–proteasome pathway, conferring
protection against exacerbated inflammatory conditions(57,61).
A decrease in glutamine levels is well established in stressful
situations, such as high intensity and prolonged exercise
(resulting in severe damage), as well as activation of inflamma-
tory processes, raising the rate of protein degrada-
tion(3,4,12,13,16,23). In this study, RE induced an increase in plasma
levels of CK and LDH enzymes. Despite the fact that CK and
LDH are known as late markers of cellular injury, our exercise
protocol was able to promote significant changes in 1 h after the
last exercise session. A recent study(62) has demonstrated that
eccentric contractions induce a significant increase in muscle CK
efflux immediately after exercise. Mechanical contractions pro-
duced by RE can induce micro-traumas in muscle fibres pro-
moting breakdown of the extracellular matrix, basal lamina and
sarcolemma, which leads to changes in membrane structure and
permeability(55). CK is located almost exclusively in brain, ske-
letal and cardiac muscle and is released to the bloodstream after
damage to the structure of non-contractile muscle elements,
which is induced by intense exercise(56). Moderate bouts of
eccentric exercise can induce physiological muscle adaptation;
however, repeated intense exercise may induce higher release of
muscle damage markers and loss of muscle proteins(63–66). This
was observed in the CTRL group, which indicates additional
muscle damage after each exercise session.
Despite harmful effects of RE training, there was a decline in
plasma CK and LDH activity in groups supplemented with
glutamine (GLN+ALA; DIP), suggesting that muscle became
more resistant to subsequent injury caused by a new session of
RE. A recent study showed inhibition of signalling proteins that
activate protein degradation after acute RE in rats supplemented
with L-alanylglutamine(67), and previous studies published by
our group indicated that L-glutamine-containing supplements
represent an effective way to maintain L-glutamine levels, which
results in attenuation of the release of substances indicative of
muscle damage and oxidative stress in trained rats(4,12,23).
The increase of lactate induced by high metabolic demand in
RE promotes mobilisation of WBC into the circulation(51). Muscle
micro-injury also induces an influx of macrophages from the
circulation in order to promote muscle repair and remodelling,
through production of pro- and anti-inflammatory
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cytokines(52,68,69). However, continuous injuries without adequate
rest periods trigger chronic inflammatory responses that can
exacerbate the underlying injuries and result in reduced perfor-
mance and impairment of athlete’s health(47,56,70). Our results
demonstrate that RE triggered an inflammatory response com-
prising stimulation of production of pro- and anti-inflammatory
mediators.
A bout of heavy RE triggers a transient inflammatory response
stimulating pro- and anti-inflammatory cytokine production(52).
Cytokines play an integrative and regulatory role mediating
intercellular communication locally or systemically(47). According
to our results, the exercise protocol induced inflammation by
production of pro-inflammatory molecules IL-1β and TNF-α.
Exercise induces robust increase of IL-6 from contracting skeletal
muscle, and this myokine stimulates the appearance of anti-
inflammatory mediators, such as IL-10, besides inhibiting the
production of TNF-α(29,52,69,71). It has been reported that factors
other than muscle damage, such as stress hormone secretion,
increase plasma concentrations of pro-inflammatory cyto-
kines(71,72), which may explain the plasma increase of IL-6 in this
study. Moreover, the magnitude and profile of cytokine response
to the exercise may differ in relation to changes in systemic v.
local factors during exercise(64).
IL-6 has been considered to have a central role in the cyto-
kine response. Enhanced by muscle contraction, IL-6 release is
related to changes in Ca homoeostasis, and mRNA levels of IL-6
in skeletal muscle are increased under conditions of low
glycogen(68,71). Nonetheless, the relation between glycogen
depletion and cytokine production is not completely clear(73).
A limitation in the current study is that muscle glycogen
depletion was not analysed, and it could provide new insights.
The RE protocol used in the present work promoted high
metabolic activity indicated by increased lactate and, therefore,
higher IL-6 concentration in muscle. Higher levels of IL-6 were
also observed in plasma of trained and supplemented rats.
Pedersen et al.(72) demonstrated that IL-6 induces lipolysis and
acts in a hormone-like manner, thus mobilising extracellular
substrates or increasing substrate delivery. Although supplemented
groups received more energetic substrate, they were associated
with lower weight gain, suggesting lipolytic effects of IL-6. How-
ever, lower IL-6 levels were observed in EDL muscle of supple-
mented groups, thus allowing for use of non-lipid fuel supplies.
After eccentric exercise, IL-10 and MCP-1 are increased in an
intensity-dependent manner(47) in an attempt to contain the
inflammation(58). Produced by a variety of cell types, MCP-1
recruit monocytes into foci of active inflammation and is required
for successful muscle regeneration. Impaired muscle regeneration
in MCP-1− /− mice suggests an important role for macrophages
and MCP-1 in the tissue reparative processes(74). As observed in
this study, because of greater metabolic demand and exercise-
induced stress, the concentrations of MCP-1 were increased in the
CTRL group. Glutamine administration in both forms was effective
to raise plasma concentrations of MCP-1, leading to high capacity
of cellular protection. In this sense, increased production of anti-
inflammatory mediators might limit the production of pro-
inflammatory cytokines associated with prolonged damage(24,29).
Taken together, these findings demonstrate that chronic oral
supplementations with L-glutamine and L-alanine in their free
form or as a dipeptide induce cyprotective effects mediated by
HSP70 responses, following experimental progressive RE and
attenuate harmful and inflammatory effects of RE. L-Glutamine-
containing supplements enhanced glutamine availability in
plasma and skeletal muscle, which may have stimulated HSP70
higher levels in PBMC and EDL muscle, and reduced
DNA-binding activity of NF-kB, supressing inflammation and
muscle damage induced by heavy RE.
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